Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mark Easley

Orthopaedic Surgery Durham, NC Medical Doctor

NPI 1790872430 CMS profile 263341

40 Duke Medicine Cir, Durham, NC 27710

Open in the dashboard

General payments

$4,042,821

1,198 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$54,449

1 holding reported · through program year 2025

Research they led as principal investigator

$87,294 paid to institutions, not to them · program years 2022–2025

Through program year 2025, Mark Easley of Durham, NC is reported in the CMS Open Payments database as having received $4,042,821 across 1,198 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $87,294 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $54,449 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,197,054 198
2024 General $883,088 127
2023 General $566,121 140
2022 General $573,856 277
2021 General $509,837 303
2020 General $147,069 81
2019 General $165,796 72
2025 Ownership $54,449 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mark Easley
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Mark Easley were reported at $1,197,054. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Mark Easley Orthopaedic Surgery median Middle half National median
2019 $165,796 $644 $140–$2,844 $163
2020 $147,069 $312 $75–$1,860 $114
2021 $509,837 $520 $117–$2,495 $132
2022 $573,856 $598 $128–$2,731 $149
2023 $566,121 $461 $128–$2,264 $160
2024 $883,088 $497 $134–$2,475 $164
2025 $1,197,054 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Treace Medical Concepts, Inc. $2,340,832 651 payments
  2. Exactech, Inc. $1,131,061 226 payments
  3. Vilex in Tennessee, Inc. $233,830 117 payments
  4. Paragon 28, Inc. $233,713 79 payments
  5. Encore Medical, LP $22,832 10 payments
  6. Bioventus LLC $13,787 17 payments
  7. Arthrex, Inc. $10,814 27 payments
  8. restor3d, inc. $10,447 2 payments
  9. SouthTech Orthopedics $7,946 8 payments
  10. International Life Sciences $7,750 2 payments
  11. Other $29,810 59 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $2,305,972 91 payments
  2. Consulting Fee $1,488,808 369 payments
  3. Travel and Lodging $163,236 401 payments
  4. Education $32,859 8 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $25,200 12 payments
  6. Food and Beverage $24,651 315 payments
  7. Honoraria $2,000 1 payment
  8. Gift $95 1 payment
Products named General payments · program years 2019–2025
  1. LAPIPLASTY SYSTEM Foot And Ankle $1,161,185 308 payments
  2. LAPIPLASTY SYSTEM 1 $955,099 106 payments
  3. VANTAGE Orthopaedic $534,041 77 payments
  4. EQUINOXE $348,140 71 payments
  5. Lapiplasty System Y $215,549 196 payments
  6. VANTAGE Orthopaedic $182,168 18 payments
  7. Product Portfolio $170,239 53 payments
  8. HINTERMANN $124,492 19 payments
  9. PORTFOLIO $59,420 11 payments
  10. DYNEX $42,055 7 payments
  11. Other $138,243 232 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

34

Median for Orthopedic Surgery: 203

Drug cost

$35

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin Generic 18 $22
Clindamycin Hcl Generic 16 $14

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 60 billing codes

Paid by Medicare

$135,251

Medicare's payments for the services billed

Medicare patients

454

Average age 72

Services billed

982

258 women, 196 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 66%
Ischemic heart disease 22%
Osteoporosis 19%
Depression 17%
Diabetes 16%
Chronic kidney disease 16%
Atrial fibrillation 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1,198 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record